Ayurvedic Management of Eosinophilic Esophagitis (Amashayagatavata) -A case report
DOI:
https://doi.org/10.70066/jahm.v14i4.2718Keywords:
Amashayagatavata, Case Report, Eosinophilic Esophagitis, Panchakarma, Yoga Basti.Abstract
Background: Eosinophilic Esophagitis (EoE) is a chronic immune-mediated esophageal disorder, often resistant to available standard therapies such as corticosteroids. A condition where a type of white blood cell (eosinophil) builds up in the esophagus, causing inflammation, tissue damage, and dysfunction. It causes chronic swallowing difficulties, food impaction, and pain, often requiring dietary changes, medication, or endoscopic dilation to manage. Clinical Findings: A 23year old male patient visited to hospital presented with complaints of dysphagia, epigastric burning vomiting sensation and burping continued since last four years. Intervention: Under Ayurvedic assessment, this case was taken under spectrum of Amashayagatavata, and a combined protocol of Panchakarma therapy and internal medication was administered. The patient underwent an 8-day yogabasti regimen comprising Niruhabasti with Yashtimadhu Ksheerpaka and a polyherbal kalka including Guduchi, Manjishtha, and Shatapushpa, and Matra basti with Dadimadi Ghrita. Oral medicines included Dhanwantaram Vati, Kamdudha with Mukta, Anuloma DS, and Vomitab syrup. Outcome: USG after two months was normal; endoscopy revealed resolution of eosinophilic inflammation and sliding hiatus hernia. Eosinophil count dropped from 986 cells/cmm to 330 cells/cmm. Symptom resolution was documented via Patient Relief Scale, endoscopic reassessment, and a Quality of Life (QOL) scale. Conclusion: The case illustrates a promising comprehensive approach with yoga niruha basti pattern along shaman yogas for chronic Eosinophilic esophagitis with a seven days IPD and four months follow ups period without any adverse effect reported during treatment with Ayurveda showed patient improvement warranting larger controlled studies.
References
Muir A, Falk GW. Eosinophilic Esophagitis: A Review. Journal of the American Medical Association. 2021;326(13):1310–1318. Available from: https://doi.org/10.1001/jama.2021.14920
Shin J, et al. Global Incidence and Prevalence of Eosinophilic Esophagitis, 1976–2022: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2023 Dec;21(13):3270–3284.e77. Available from: https://doi.org/10.1016/j.cgh.2023.06.005
Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. Journal of Allergy and Clinical Immunology. 2011;128(1):3–20.e6.Availablefrom: http://dx.doi.org/10.1016/j.jaci.2011.02.040
Dellon ES. Eosinophilic esophagitis. 2020 edition, Gastroenterology Clinics of North America. 2013;42(1):133–153.
Penti P, Putnam PE, Collins MH, Rothenberg ME. Efficacy of budesonide in eosinophilic esophagitis. American Journal of Gastroenterology. 2012;107(3):456–464. Available from http://10.1007/s40268-018-0253-9
Sharma M, Dadhich A, Sharma V. Concept of Āmāshaya-gata Roga in Ayurveda: A review. AYU – An International Quarterly Journal of Research in Ayurveda. 2019;40(2):75–80. Available from http:// doi:10.4103/ayu.AYU_185_18
Penman ID, Ralston SH, Strachan MWJ, Hobson RP, editors. Davidson’s Principles and Practice of Medicine. 25th edition, Elsevier; Edinburgh; 2022;1156
Sharma S (editor). Ashtanga Hridaya of Vagbhata, Sutrasthana, chapter 10, verse no.18–19. 2019 edition, Varanasi; Chaukhambha Surbharati Prakashan; 2019;176.
Sharma S (editor). Ashtanga Hridaya of Vagbhata, Sutrasthana, chapter 10, verse no.20–21. 2019 edition, Varanasi; Chaukhambha Surbharati Prakashan; 2019;177.
Shastri L (editor). Bhaishajya Ratnavali of Govinda Dasa, Vatavyadhi Chikitsa Prakarana, chapter 10, verse no.22–23. 2018 edition, Varanasi; Chaukhambha Prakashan; 2018;178.
Shastri L (editor). Bhaishajya Ratnavali of Govinda Dasa, Amlapitta Chikitsa Prakarana, chapter 10, verse no.24–25. 2018 edition, Varanasi; Chaukhambha Prakashan; 2018;179.
Ayurvedic Formulary of India. Part I. 2nd edition, Ministry of AYUSH, Government of India; New Delhi; 2003;354
Ayurvedic Formulary of India. Part II. Ministry of AYUSH, Government of India; New Delhi; 2007;355
Sharma PV. Dravyaguna Vijnana. Vol. II. Varanasi; edition 2019, Chaukhambha Bharati Academy; 2013;453
Hirano I, Chan ES, Rank MA, et al. AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters clinical guidelines for the management of eosinophilic esophagitis. Gastroenterology. 2020;158(6):1776–1786. Available from http:// 10.1053/j.gastro.2020.02.038
Sharma S (editor). Ashtanga Hridaya of Vagbhata, Sutrasthana, chapter 11, verse no.16–17. 2019 edition, Varanasi; Chaukhambha Surbharati Prakashan; 2019;213.
Sharma RK, Dash B (translators). Charaka Samhita of Agnivesha, Chikitsasthana, chapter 30, verse no.34. 2018 edition, Varanasi; Chaukhambha Sanskrit Series Office; 2018;256.
Pastorino G, Cornara L, Soares S, Rodrigues F, Oliveira MBPP. Liquorice (Glycyrrhiza glabra), Tinospora cordifolia, and Rubia cordifolia: phytochemical and pharmacological relevance in inflammatory and immune-mediated disorders. Phytotherapy Research. 2018;32(12):2323–2339. Available from: https://doi.org/10.1002/ptr.6176
Shastri L (editor). Bhaishajya Ratnavali of Govinda Dasa, Vatavyadhi and Amlapitta Chikitsa Prakarana, chapter 30, verse no.54–55. 2018 edition, Varanasi; Chaukhambha Prakashan; 2018;546.
Sharma PV. Dravyaguna Vijnana. Vol. II. Varanasi;2018 edition, Chaukhambha Bharati Academy; 2013; 289
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Rohan Mohandas, Kartik Sharma, Suhas kumar Shetty , Aniket Ramesh Chaudhari

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.